Singapore vs Thailand: New cases tested for RR-/MDR-TB
Singapore
84.0%
in 2024
Thailand
84.0%
in 2024
Singapore rank
122nd
Thailand rank
122nd
New cases tested for RR-/MDR-TB over time
- Singapore
- Thailand
How they compare
Singapore currently reports 84.0% against 84.0% in Thailand, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was Singapore ahead.
Singapore ranks 122nd and Thailand ranks 122nd of 192 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Singapore | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.3% | 28.6% | 70.7% | Singapore |
| 2020s | 91.8% | 79.6% | 12.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Singapore or Thailand?
- Singapore, at 84.0% against 84.0% in Thailand as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Singapore and Thailand?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Thailand?
- 12 years are reported by both, from 2013 to 2024.
- How do Singapore and Thailand rank globally for new cases tested for rr-/mdr-tb?
- Singapore ranks 122nd and Thailand ranks 122nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.